Holmes, H.
Mayo Clinic
Texas Oncology‐Baylor Charles A. Sammons Cancer Center Dallas Texas USA
Citations 1
LISOCABTAGENE MARALEUCEL (LISO‐CEL) VERSUS STANDARD OF CARE (SOC) AS SECOND‐LINE THERAPY IN LARGE B‐CELL LYMPHOMA (TRANSFORM STUDY): SUBGROUP ANALYSES BY PRIOR THERAPY RESPONSE
Ghesquières, Hervé , Ghosh, Monalisa , López‐Guillermo, Armando , Feldman, Tatyana , Sauter, Craig S. , Bonin, Malte von , Montheard, Sandrine, Previtali, Alessandro , Nastoupil, Loretta J. , Kamdar, Manali , Chavez, Julio C , Holmes, H., Martínez‐López, Joaquín , Novak, Urban , Ribrag, Vincent , Roddie, Claire , Waller, Edmund K. , Rosenthal, Allison , Karmali, Reem , Abramson, Jeremy S.
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 212-214
